Hepatitis and rhabdomyolysis in a patient with hormone refractory prostate cancer on ketoconazole and concurrent lovastatin therapy.
Stein
C A
CA
Albert Einstein College of Medicine, Montefiore Cancer Center, Bronx, NY 10467, USA. cstein@montefiore.org
Goel
Sanjay
S
Ghavamian
Reza
R
D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D004347:Drug Interactions; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy*; D007654:Ketoconazole / Q000009:adverse effects*; D008148:Lovastatin / Q000009:adverse effects*; D008297:Male; D011471:Prostatic Neoplasms / Q000150:complications / Q000188:drug therapy*; D012206:Rhabdomyolysis / Q000139:chemically induced*; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008148:Lovastatin; D007654:Ketoconazole